Implantable Neurostimulators Industry Research Report 2025

Summary

An implantable neurostimulator is a surgically placed device about the size of a stopwatch. It delivers mild electrical signals to the epidural space near your spine through one or more thin wires, called leads. A complete implantable neurostimulation system includes several components: Neurostimulator, Leads, Physician’s programmer, Patient’s programmer.

According to APO Research, the global Implantable Neurostimulators market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Implantable Neurostimulators is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Implantable Neurostimulators is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Implantable Neurostimulators is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Implantable Neurostimulators include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, NeuroPace, Synapse Biomedical, NeuroSigma, ReShape Lifesciences and ElectroCore Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Implantable Neurostimulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neurostimulators.

The report will help the Implantable Neurostimulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Implantable Neurostimulators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Neurostimulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Implantable Neurostimulators Segment by Company

Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
NeuroPace
Synapse Biomedical
NeuroSigma
ReShape Lifesciences
ElectroCore Medical
Inspire Medical
NEUROS
SPR
IMTHERA
NEVRO

Implantable Neurostimulators Segment by Type

Deep Brain Stimulators
Spinal Cord Stimulators
Vagal Nerve Stimulators
Sacral Nerve Stimulators
Gastric Stimulators
Others

Implantable Neurostimulators Segment by Application

Parkinson's Disease
Epilepsy
Pain
Others

Implantable Neurostimulators Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Neurostimulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Implantable Neurostimulators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Neurostimulators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Implantable Neurostimulators manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Implantable Neurostimulators by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Implantable Neurostimulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Implantable Neurostimulators Market Size (2020-2031)
2.2.2 Global Implantable Neurostimulators Sales (2020-2031)
2.2.3 Global Implantable Neurostimulators Market Average Price (2020-2031)
2.3 Implantable Neurostimulators by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Deep Brain Stimulators
2.3.3 Spinal Cord Stimulators
2.3.4 Vagal Nerve Stimulators
2.3.5 Sacral Nerve Stimulators
2.3.6 Gastric Stimulators
2.3.7 Others
2.4 Implantable Neurostimulators by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Parkinson's Disease
2.4.3 Epilepsy
2.4.4 Pain
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Implantable Neurostimulators Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Implantable Neurostimulators Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Implantable Neurostimulators Revenue of Manufacturers (2020-2025)
3.4 Global Implantable Neurostimulators Average Price by Manufacturers (2020-2025)
3.5 Global Implantable Neurostimulators Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Implantable Neurostimulators, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Implantable Neurostimulators, Product Type & Application
3.8 Global Manufacturers of Implantable Neurostimulators, Established Date
3.9 Global Implantable Neurostimulators Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Medtronic
4.1.1 Medtronic Company Information
4.1.2 Medtronic Business Overview
4.1.3 Medtronic Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Medtronic Implantable Neurostimulators Product Portfolio
4.1.5 Medtronic Recent Developments
4.2 Boston Scientific
4.2.1 Boston Scientific Company Information
4.2.2 Boston Scientific Business Overview
4.2.3 Boston Scientific Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Boston Scientific Implantable Neurostimulators Product Portfolio
4.2.5 Boston Scientific Recent Developments
4.3 St. Jude Medical
4.3.1 St. Jude Medical Company Information
4.3.2 St. Jude Medical Business Overview
4.3.3 St. Jude Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.3.4 St. Jude Medical Implantable Neurostimulators Product Portfolio
4.3.5 St. Jude Medical Recent Developments
4.4 Cyberonics
4.4.1 Cyberonics Company Information
4.4.2 Cyberonics Business Overview
4.4.3 Cyberonics Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Cyberonics Implantable Neurostimulators Product Portfolio
4.4.5 Cyberonics Recent Developments
4.5 NeuroPace
4.5.1 NeuroPace Company Information
4.5.2 NeuroPace Business Overview
4.5.3 NeuroPace Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.5.4 NeuroPace Implantable Neurostimulators Product Portfolio
4.5.5 NeuroPace Recent Developments
4.6 Synapse Biomedical
4.6.1 Synapse Biomedical Company Information
4.6.2 Synapse Biomedical Business Overview
4.6.3 Synapse Biomedical Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Synapse Biomedical Implantable Neurostimulators Product Portfolio
4.6.5 Synapse Biomedical Recent Developments
4.7 NeuroSigma
4.7.1 NeuroSigma Company Information
4.7.2 NeuroSigma Business Overview
4.7.3 NeuroSigma Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.7.4 NeuroSigma Implantable Neurostimulators Product Portfolio
4.7.5 NeuroSigma Recent Developments
4.8 ReShape Lifesciences
4.8.1 ReShape Lifesciences Company Information
4.8.2 ReShape Lifesciences Business Overview
4.8.3 ReShape Lifesciences Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.8.4 ReShape Lifesciences Implantable Neurostimulators Product Portfolio
4.8.5 ReShape Lifesciences Recent Developments
4.9 ElectroCore Medical
4.9.1 ElectroCore Medical Company Information
4.9.2 ElectroCore Medical Business Overview
4.9.3 ElectroCore Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.9.4 ElectroCore Medical Implantable Neurostimulators Product Portfolio
4.9.5 ElectroCore Medical Recent Developments
4.10 Inspire Medical
4.10.1 Inspire Medical Company Information
4.10.2 Inspire Medical Business Overview
4.10.3 Inspire Medical Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Inspire Medical Implantable Neurostimulators Product Portfolio
4.10.5 Inspire Medical Recent Developments
4.11 NEUROS
4.11.1 NEUROS Company Information
4.11.2 NEUROS Business Overview
4.11.3 NEUROS Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.11.4 NEUROS Implantable Neurostimulators Product Portfolio
4.11.5 NEUROS Recent Developments
4.12 SPR
4.12.1 SPR Company Information
4.12.2 SPR Business Overview
4.12.3 SPR Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.12.4 SPR Implantable Neurostimulators Product Portfolio
4.12.5 SPR Recent Developments
4.13 IMTHERA
4.13.1 IMTHERA Company Information
4.13.2 IMTHERA Business Overview
4.13.3 IMTHERA Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.13.4 IMTHERA Implantable Neurostimulators Product Portfolio
4.13.5 IMTHERA Recent Developments
4.14 NEVRO
4.14.1 NEVRO Company Information
4.14.2 NEVRO Business Overview
4.14.3 NEVRO Implantable Neurostimulators Sales, Revenue and Gross Margin (2020-2025)
4.14.4 NEVRO Implantable Neurostimulators Product Portfolio
4.14.5 NEVRO Recent Developments
5 Global Implantable Neurostimulators Market Scenario by Region
5.1 Global Implantable Neurostimulators Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Implantable Neurostimulators Sales by Region: 2020-2031
5.2.1 Global Implantable Neurostimulators Sales by Region: 2020-2025
5.2.2 Global Implantable Neurostimulators Sales by Region: 2026-2031
5.3 Global Implantable Neurostimulators Revenue by Region: 2020-2031
5.3.1 Global Implantable Neurostimulators Revenue by Region: 2020-2025
5.3.2 Global Implantable Neurostimulators Revenue by Region: 2026-2031
5.4 North America Implantable Neurostimulators Market Facts & Figures by Country
5.4.1 North America Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Implantable Neurostimulators Sales by Country (2020-2031)
5.4.3 North America Implantable Neurostimulators Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Implantable Neurostimulators Market Facts & Figures by Country
5.5.1 Europe Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Implantable Neurostimulators Sales by Country (2020-2031)
5.5.3 Europe Implantable Neurostimulators Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Implantable Neurostimulators Market Facts & Figures by Country
5.6.1 Asia Pacific Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Implantable Neurostimulators Sales by Country (2020-2031)
5.6.3 Asia Pacific Implantable Neurostimulators Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Implantable Neurostimulators Market Facts & Figures by Country
5.7.1 South America Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Implantable Neurostimulators Sales by Country (2020-2031)
5.7.3 South America Implantable Neurostimulators Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Implantable Neurostimulators Market Facts & Figures by Country
5.8.1 Middle East and Africa Implantable Neurostimulators Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Implantable Neurostimulators Sales by Country (2020-2031)
5.8.3 Middle East and Africa Implantable Neurostimulators Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Implantable Neurostimulators Sales by Type (2020-2031)
6.1.1 Global Implantable Neurostimulators Sales by Type (2020-2031) & (K Units)
6.1.2 Global Implantable Neurostimulators Sales Market Share by Type (2020-2031)
6.2 Global Implantable Neurostimulators Revenue by Type (2020-2031)
6.2.1 Global Implantable Neurostimulators Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Implantable Neurostimulators Revenue Market Share by Type (2020-2031)
6.3 Global Implantable Neurostimulators Price by Type (2020-2031)
7 Segment by Application
7.1 Global Implantable Neurostimulators Sales by Application (2020-2031)
7.1.1 Global Implantable Neurostimulators Sales by Application (2020-2031) & (K Units)
7.1.2 Global Implantable Neurostimulators Sales Market Share by Application (2020-2031)
7.2 Global Implantable Neurostimulators Revenue by Application (2020-2031)
7.2.1 Global Implantable Neurostimulators Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Implantable Neurostimulators Revenue Market Share by Application (2020-2031)
7.3 Global Implantable Neurostimulators Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Implantable Neurostimulators Value Chain Analysis
8.1.1 Implantable Neurostimulators Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Implantable Neurostimulators Production Mode & Process
8.2 Implantable Neurostimulators Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Implantable Neurostimulators Distributors
8.2.3 Implantable Neurostimulators Customers
9 Global Implantable Neurostimulators Analyzing Market Dynamics
9.1 Implantable Neurostimulators Industry Trends
9.2 Implantable Neurostimulators Industry Drivers
9.3 Implantable Neurostimulators Industry Opportunities and Challenges
9.4 Implantable Neurostimulators Industry Restraints
10 Report Conclusion
11 Disclaimer

Loading...

In this report,

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings